The availability of highly sensitive troponin assays (hsTn) allows the safe clinical application of international recommendations and the introduction of fast-track protocols for the definition of AMI. However, hsTn assays have not always been welcomed by clinicians, claiming an increase in false-positive results. To guide interpretation of results, laboratory specialists need to get involved in communicating with clinicians through education, test interpretation and internal audits of test usage and patient outcomes.
Kurse mit 'cardiac markers' markiert
Clinical Biochemistry: Nein
< 1 hour: Nein
1-2 hours: Nein
> 2 hours: Nein